Neuroinvasion and Inflammation in Viral Central Nervous System Infections

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Dahm, Tobias ^a   Rudolph, Henriette ^a   Schwerk, Christian ^a   Schroten, Horst ^a   Tenenbaum, Tobias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; FLAVIVIRIDAE; HERPESVIRIDAE; HUMAN; IMMUNE RESPONSE; MOLECULAR MECHANICS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PARAMYXOVIRIDAE; PICORNAVIRIDAE; POLYOMAVIRIDAE; RETROVIRIDAE; REVIEW; RHABDOVIRIDAE; TOGAVIRIDAE; VIRUS INFECTION; ANIMAL; CELL MOTION; CYTOLOGY; INFLAMMATION; LEUKOCYTE; METABOLISM; PATHOGENICITY; PATHOLOGY; VIROLOGY; VIRUS;

ANIMALS; BLOOD-BRAIN BARRIER; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM INFECTIONS; CHEMOKINES; CYTOKINES; FLAVIVIRIDAE; HERPESVIRIDAE; HUMANS; INFLAMMATION; LEUKOCYTES; PARAMYXOVIRIDAE; PICORNAVIRIDAE; RETROVIRIDAE; TOGAVIRIDAE; VIRUS DISEASES; VIRUSES;

EID: 84975138319     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/8562805     Document Type: Review

References (179)

1. P. A. Swanson II and D. B. McGavern, "Viral diseases of the central nervous system," Current Opinion in Virology, vol. 11, pp. 44-54, 2015.
2. A. G. Michos, V. P. Syriopoulou, C. Hadjichristodoulou et al., "Aseptic meningitis in children: analysis of 506 cases," PloS ONE, vol. 2, no. 7, article e674, 2007.
3. H. A. Rotbart, "Viral meningitis," Seminars in Neurology, vol. 20, no. 3, pp. 277-292, 2000.
4. P. Rantakallio, M. Leskinen, and L. von Wendt, "Incidence and prognosis of central nervous system infections in a birth cohort of 12,000 children," Scandinavian Journal of Infectious Diseases, vol. 18, no. 4, pp. 287-294, 1986.
5. + T cells: evidence for trafficking through choroid plexus and meninges via P-selectin," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8389-8394, 2003.
6. + T cells dominate the normal cerebrospinal fluid," Cytometry Part B: Clinical Cytometry, vol. 80, no. 1, pp. 43-50, 2011.
7. S. Cepok, B. Rosche, V. Grummel et al., "Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis," Brain, vol. 128, no. 7, pp. 1667-1676, 2005.
8. S. Cepok, G. von Geldern, V. Grummel et al., "Accumulation of class switched IgD-IgM-memory B cells in the cerebrospinal fluid during neuroinflammation," Journal of Neuroimmunology, vol. 180, no. 1-2, pp. 33-39, 2006.
9. D. Michlmayr, C. S. McKimmie, M. Pingen et al., "Defining the chemokine basis for leukocyte recruitment during viral encephalitis," Journal of virology, vol. 88, no. 17, pp. 9553-9567, 2014.
10. K. Fukushima, A. Ishiguro, and T. Shimbo, "Transient elevation of granulocyte colony-stimulating factor levels in cerebrospinal fluid at the initial stage of aseptic meningitis in children," Pediatric Research, vol. 37, no. 2, pp. 160-164, 1995.
11. D. Demeestere, C. Libert, and R. E. Vandenbroucke, "Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders," Drug Discovery Today, vol. 20, no. 8, pp. 928-941, 2015.
12. N. J. Abbott, A. A. K. Patabendige, D.E.M. Dolman, S. R. Yusof, and D. J. Begley, "Structure and function of the blood-brain barrier," Neurobiology of Disease, vol. 37, no. 1, pp. 13-25, 2010.
13. N. J. Abbott, L. Rönnbäck, and E. Hansson, "Astrocyteendothelial interactions at the blood-brain barrier," Nature Reviews Neuroscience, vol. 7, no. 1, pp. 41-53, 2006.
14. S. Tietz and B. Engelhardt, "Brain barriers: crosstalk between complex tight junctions and adherens junctions," The Journal of Cell Biology, vol. 209, no. 4, pp. 493-506, 2015.
15. K. R. Spindler and T.-H. Hsu, "Viral disruption of the bloodbrain barrier," Trends in Microbiology, vol. 20, no. 6, pp. 282-290, 2012.
16. N. Strazielle and J.-F. Ghersi-Egea, "Choroid plexus in the central nervous system: biology and physiopathology," Journal of Neuropathology and Experimental Neurology, vol. 59, no. 7, pp. 561-574, 2000.
17. H. Wolburg and W. Paulus, "Choroid plexus: biology and pathology," Acta Neuropathologica, vol. 119, no. 1, pp. 75-88, 2010.
18. N. Strazielle and J.-F. Ghersi-Egea, "In vitro models of the blood-cerebrospinal fluid barrier and their use in neurotoxicological research," in Cell Culture Techniques, vol. 56 of Neuromethods, pp. 161-184, Humana Press, 2011.
19. H. Wolburg and A. Lippoldt, "Tight junctions of the bloodbrain barrier: development, composition and regulation," Vascular Pharmacology, vol. 38, no. 6, pp. 323-337, 2002.
20. B. Engelhardt, "Development of the blood-brain interface," in Blood-Brain Barriers, pp. 9-39, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2007.
21. C. Lehner, R. Gehwolf, H. Tempfer et al., "Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases," Antioxidants and Redox Signaling, vol. 15, no. 5, pp. 1305-1323, 2011.
22. A. Hartsock and W. J. Nelson, "Adherens and tight junctions: structure, function and connections to the actin cytoskeleton," Biochimica et Biophysica Acta (BBA)-Biomembranes, vol. 1778, no. 3, pp. 660-669, 2008.
23. M. Coureuil, O. Join-Lambert, H. Lécuyer, S. Bourdoulous, S. Marullo, and X. Nassif, "Mechanism of meningeal invasion by Neisseria meningitidis," Virulence, vol. 3, no. 2, pp. 164-172, 2012.
24. E. Mairey, A. Genovesio, E. Donnadieu et al., "Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier," Journal of Experimental Medicine, vol. 203, no. 8, pp. 1939-1950, 2006.
25. X. Nassif, S. Bourdoulous, E. Eugene, and P.-O. Couraud, "How do extracellular pathogens cross the blood-brain barrier?" Trends in Microbiology, vol. 10, no. 5, pp. 227-232, 2002.
26. F. Iovino, G. Molema, and J. J. E. Bijlsma, "Streptococcus pneumoniae interacts with pIgR expressed by the brain microvascular endothelium but does not co-localize with PAF receptor," PLoS ONE, vol. 9, no. 5, Article ID e97914, 2014.
27. A. Y. Jong, M. F. Stins, S.-H. Huang, S. H. M. Chen, and K. S. Kim, "Traversal of Candida albicans across human blood-brain barrier in vitro," Infection and Immunity, vol. 69, no. 7, pp. 4536-4544, 2001.
28. Y. Liu, R. Mittal, N. V. Solis, N. V. Prasadarao, and S. G. Filler, "Mechanisms of candida albicans trafficking to the brain," PLoS Pathogens, vol. 7, no. 10, Article ID e1002305, 2011.
29. T. Wang, T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig, and R. A. Flavell, "Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis," Nature Medicine, vol. 10, no. 12, pp. 1366-1373, 2004.
30. M. S. Diamond and R. S. Klein, "West Nile virus: crossing the blood-brain barrier," Nature Medicine, vol. 10, no. 12, pp. 1294-1295, 2004.
31. V. S. R. Atluri, M. Hidalgo, T. Samikkannu et al., "Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update," Frontiers in Cellular Neuroscience, vol. 9, article 212, 2015.
32. H. Wang, J. Sun, and H. Goldstein, "Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide," Journal of Virology, vol. 82, no. 15, pp. 7591-7600, 2008.
33. J. Sellner, F. Simon, U. Meyding-Lamade, and S. L. Leib, "Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation," Brain Research, vol. 1125, no. 1, pp. 155-162, 2006.
34. C. Schwerk, T. Papandreou, D. Schuhmann et al., "Polar invasion and translocation of Neisseria meningitidis and Streptococcus suis in a novel human model of the blood-cerebrospinal fluid barrier," PLoS ONE, vol. 7, no. 1, Article ID e30069, 2012.
35. S. E. Sanford, "Gross and histopathological findings in unusual lesions caused by Streptococcus suis in pigs. II. Central nervous system lesions," Canadian Journal of Veterinary Research, vol. 51, no. 4, pp. 486-489, 1987.
36. T. Tenenbaum, T. Papandreou, D. Gellrich et al., "Polar bacterial invasion and translocation of Streptococcus suis across the blood-cerebrospinal fluid barrier in vitro," Cellular Microbiology, vol. 11, no. 2, pp. 323-336, 2009.
37. B. Pron, M.-K. Taha, C. Rambaud et al., "Interactionof Neisseria meningitidis with the components of the blood-brain barrier correlates with an increased expression of PilC," Journal of Infectious Diseases, vol. 176, no. 5, pp. 1285-1292, 1997.
38. J. Guarner, P. W. Greer, A. Whitney et al., "Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays," The American Journal of Clinical Pathology, vol. 122, no. 5, pp. 754-764, 2004.
39. A. L. Smith, "Pathogenesis of Haemophilus influenzae meningitis," Pediatric Infectious Disease Journal, vol. 6, no. 8, pp. 783-786, 1987.
40. B. L. Wiedermann, E. P. Hawkins, G. S. Johnson, L. B. Lamberth, E. O. Mason, and S. L. Kaplan, "Pathogenesis of labyrinthitis associated with Haemophilus influenzae type b meningitis in infant rats," The Journal of Infectious Diseases, vol. 153, no. 1, pp. 27-32, 1986.
41. R. S. Daum, D. W. Scheifele, P. V. Syriopoulou, D. Averill, and A. L. Smith, "Ventricular involvement in experimental Hemophilus influenzae meningitis," Journal of Pediatrics, vol. 93, no. 6, pp. 927-930, 1978.
42. T. Gründler, N. Quednau, C. Stump et al., "The surface proteins InlA and InlB are interdependently required for polar basolateral invasion by Listeria monocytogenes in a human model of the blood-cerebrospinal fluid barrier," Microbes and Infection, vol. 15, no. 4, pp. 291-301, 2013.
43. E. Mylonakis, E. L. Hohmann, and S. B. Calderwood, "Central nervous system infection with Listeria monocytogenes: 33 years' experience at a general hospital and reviewof 776 episodes from the literature," Medicine, vol. 77, no. 5, pp. 313-336, 1998.
44. N. Prats, V. Briones, M. M. Blanco et al., "Choroiditis and meningitis in experimental murine infection with Listeria monocytogenes," European Journal of Clinical Microbiology & Infectious Diseases, vol. 11, no. 8, pp. 744-747, 1992.
45. R. E. Rhoades, J. M. Tabor-Godwin, G. Tsueng, and R. Feuer, "Enterovirus infections of the central nervous system," Virology, vol. 411, no. 2, pp. 288-305, 2011.
46. R. Feuer, I. Mena, R. R. Pagarigan, S. Harkins, D. E. Hassett, and J. L. Whitton, "Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease," American Journal of Pathology, vol. 163, no. 4, pp. 1379-1393, 2003.
47. T. Couderc, F. Chrétien, C. Schilte et al., "A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease," PLoS Pathogens, vol. 4, no. 2, article e29, 2008.
48. H. Schneider, C. E. Weber, J. Schoeller et al., "Chemotaxis of T-cells after infection of human choroid plexus papilloma cells with Echovirus 30 in an in vitro model of the bloodcerebrospinal fluid barrier," Virus Research, vol. 170, no. 1-2, pp. 66-74, 2012.
49. C. Schwerk, T. Tenenbaum, K. S. Kim, and H. Schroten, "The choroid plexus-a multi-role player during infectious diseases of the CNS," Frontiers in Cellular Neuroscience, vol. 9, article 80, 2015.
50. R. Ren and V. R. Racaniello, "Poliovirus spreads from muscle to the central nervous system by neural pathways," Journal of Infectious Diseases, vol. 166, no. 4, pp. 747-752, 1992.
51. V. R. Racaniello, "One hundred years of poliovirus pathogenesis," Virology, vol. 344, no. 1, pp. 9-16, 2006.
52. E. M. Ponnuraj, T. Jacob John, M. J. Levin, and E. A. F. Simoes, "Sabin attenuated LSc/2ab strain of poliovirus spreads to the spinal cord from a peripheral nerve in bonnet monkeys (Macaca radiata)," Journal of General Virology, vol. 82, part 6, pp. 1329-1338, 2001.
53. I. Mori, Y. Nishiyama, T. Yokochi, and Y. Kimura, "Olfactory transmission of neurotropic viruses," Journal of Neuro Virology, vol. 11, no. 2, pp. 129-137, 2005.
54. Y. Becker, "HSV-1 brain infection by the olfactory nerve route and virus latency and reactivation may cause learning and behavioral deficiencies and violence in children and adults: a point of view," Virus Genes, vol. 10, no. 3, pp. 217-226, 1995.
55. H. Cho and M. S. Diamond, "Immune responses to west nile virus infection in the central nervous system," Viruses, vol. 4, no. 12, pp. 3812-3830, 2012.
56. N. Nathanson, "The pathogenesis of poliomyelitis: what we don't know," Advances in Virus Research, vol. 71, pp. 1-50, 2008.
57. F. González-Scarano and J. Martín-García, "The neuropathogenesis of AIDS," Nature Reviews Immunology, vol. 5, no. 1, pp. 69-81, 2005.
58. D. Gilden, M. Nagel, R. Cohrs, R. Mahalingam, and N. Baird, "Varicella zoster virus in the nervous system," F1000Research, vol. 4, article 1356, 2015.
59. M. C.-J. Cheeran, J. R. Lokensgard, and M. R. Schleiss, "Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention," Clinical Microbiology Reviews, vol. 22, no. 1, pp. 99-126, 2009.
60. H. Agut, P. Bonnafous, and A. Gautheret-Dejean, "Laboratory and clinical aspects of human herpesvirus 6 infections," Clinical Microbiology Reviews, vol. 28, no. 2, pp. 313-335, 2015.
61. P. G. E. Kennedy and A. Chaudhuri, "Herpes simplex encephalitis," Journal of Neurology Neurosurgery and Psychiatry, vol. 73, no. 3, pp. 237-238, 2002.
62. S. Hoover, J. Ross, and J. Cohen, Epstein-Barr Virus, Williams & Wilkins, Philadelphia, Pa, USA, 2004.
63. A. Muehlenbachs, J. Bhatnagar, and S.R. Zaki, "Tissue tropism, pathology and pathogenesis of enterovirus infection," The Journal of Pathology, vol. 235, no. 2, pp. 217-228, 2015.
64. L. N. Luethy, A. K. Erickson, P. R. Jesudhasan, M. Ikizler, T. S. Dermody, and J. K. Pfeiffer, "Comparison of three neurotropic viruses reveals differences in viral dissemination to the centrl nervous system," Virology, vol. 487, pp. 1-10, 2016.
65. M. A. Verboon-Maciolek, F. Groenendaal, C. D. Hahn et al., "Human parechovirus causes encephalitis with white matter injury in neonates," Annals of Neurology, vol. 64, no. 3, pp. 266-273, 2008.
66. K. Blom, M. Braun, J. Pakalniene et al., "Specificity and dynamics of effector andmemory CD8 T cell responses in human tickborne encephalitis virus infection," PLoS Pathogens, vol. 11, no. 1, Article ID e1004622, 2015.
67. G. J. Sips, J. Wilschut, and J. M. Smit, "Neuroinvasive flavivirus infections," Reviews in Medical Virology, vol. 22, no. 2, pp. 69-87, 2012.
68. F. Li, Y. Wang, L. Yu et al., "Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection," Journal of Virology, vol. 89, no. 10, pp. 5602-5614, 2015.
69. D. L. Fisher, S. Defres, and T. Solomon, "Measles-induced encephalitis," Quarterly Journal of Medicine, vol. 108, no. 3, pp. 177-182, 2015.
70. J. S. Wolinsky, T. Klassen, and J. R. Baringer, "Persistence of neuroadaptedmumps virus in brains of newborn hamsters after intraperitoneal inoculation," Journal of Infectious Diseases, vol. 133, no. 3, pp. 260-267, 1976.
71. D. C. Hooper, A. Roy, D. A. Barkhouse, J. Li, and R. B. Kean, "Rabies virus clearance from the central nervous system," Advances in Virus Research, vol. 79, pp. 55-71, 2011.
72. M.W. Ferenczy, L. J. Marshall, C. D. S. Nelson et al., "Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain," Clinical Microbiology Reviews, vol. 25, no. 3, pp. 471-506, 2012.
73. T. Das, J. J. Hoarau, M. C. Jaffar Bandjee, M. Marianne, and P. Gasque, "Multifaceted innate immune responses engaged by astrocytes, microglia and resident dendritic cells against Chikungunya neuroinfection," Journal of General Virology, vol. 96, part 2, pp. 294-310, 2015.
74. M. Ludlow, J. Kortekaas, C. Herden et al., "Neurotropic virus infections as the cause of immediate and delayed neuropathology," Acta Neuropathologica, vol. 131, no. 2, pp. 159-184, 2016.
75. K. S. Kim, "Mechanisms of microbial traversal of the bloodbrain barrier," Nature Reviews Microbiology, vol. 6, no. 8, pp. 625-634, 2008.
76. J. E. Oakes, "Invasion of the central nervous system by herpes simplex virus type 1 after subcutaneous inoculation of immunosuppressed mice," Journal of Infectious Diseases, vol. 131, no. 1, pp. 51-57, 1975.
77. N. Q. Liu, A. S. Lossinsky, W. Popik et al., "Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogenactivated protein kinase signaling pathway," Journal of Virology, vol. 76, no. 13, pp. 6689-6700, 2002.
78. M. Fiala, D. J. Looney, M. Stins et al., "TNF-α opens a paracellular route for HIV-1 invasion across the blood-brain barrier," Molecular Medicine, vol. 3, no. 8, pp. 553-564, 1997.
79. C. Bleau, A. Filliol, M. Samson, and L. Lamontagne, "Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and beta interferon production in brain microvascular endothelial cells," Journal of Virology, vol. 89, no. 19, pp. 9896-9908, 2015.
80. J. M. Tabor-Godwin, C. M. Ruller, N. Bagalso et al., "A novel population ofmyeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS," The Journal of Neuroscience, vol. 30, no. 25, pp. 8676-8691, 2010.
81. J. E. Hazleton, J.W. Berman, and E. A. Eugenin, "Novel mechanisms of central nervous systemdamage in HIV infection," HIV AIDS, vol. 2, pp. 39-49, 2010.
82. A. Mahadevan, S. K. Shankar, P. Satishchandra et al., "Characterization of human immunodeficiency virus (HIV)-infected cells in infiltrates associated with CNS opportunistic infections in patients with HIV clade C infection," Journal of Neuropathology and Experimental Neurology, vol. 66, no. 9, pp. 799-808, 2007.
83. S. Verma, Y. Lo, M. Chapagain et al., "West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in vitro blood-brain barrier," Virology, vol. 385, no. 2, pp. 425-433, 2009.
84. W. W. Suen, N. A. Prow, R. A. Hall, and H. Bielefeldt-Ohmann, "Mechanism of west nile virus neuroinvasion: a critical appraisal," Viruses, vol. 6, no. 7, pp. 2796-2825, 2014.
85. S. M. Stamatovic, R. F. Keep, and A. V. Andjelkovic, "Brain endothelial cell-cell junctions: how to 'open' the blood brain barrier," Current Neuropharmacology, vol. 6, no. 3, pp. 179-192, 2008.
86. B. P. Daniels, D. W. Holman, L. Cruz-Orengo, H. Jujjavarapu, D. M. Durrant, and R. S. Klein, "Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals," mBio, vol. 5, no. 5, Article ID e01476-14, 2014.
87. R. M. Ransohoff and B. Engelhardt, "The anatomical and cellular basis of immune surveillance in the central nervous system," Nature Reviews Immunology, vol. 12, no. 9, pp. 623-635, 2012.
88. Y. He, Y. Yao, S. E. Tsirka, and Y. Cao, "Cell-culture models of the blood-brain barrier," Stroke, vol. 45, no. 8, pp. 2514-2526, 2014.
89. D. E. Eigenmann, G. Xue, K. S. Kim, A. V. Moses, M. Hamburger, and M. Oufir, "Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies," Fluids and Barriers of the CNS, vol. 10, no. 1, article 33, 2013.
90. C. B. Coyne, K. S. Kim, and J. M. Bergelson, "Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2," EMBO Journal, vol. 26, no. 17, pp. 4016-4028, 2007.
91. B. Brandenburg, L. Y. Lee, M. Lakadamyali, M. J. Rust, X. Zhuang, and J.M. Hogle, "Imaging poliovirus entry in live cells," PLoS Biology, vol. 5, no. 7, article e183, 2007.
92. Y. Persidsky, "Model systems for studies of leukocyte migration across the blood-brain barrier," Journal of Neuro Virology, vol. 5, no. 6, pp. 579-590, 1999.
93. W. Zheng and Q. Zhao, "Establishment and characterization of an immortalized Z310 choroidal epithelial cell line frommurine choroid plexus," Brain Research, vol. 958, no. 2, pp. 371-380, 2002.
94. L.Z. Shi, G. J. Li, S. Wang, and W. Zheng, "Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: tight junction proteins and transport properties," Toxicology in Vitro, vol. 22, no. 1, pp. 190-199, 2008.
95. M. Schroten, F.-G. Hanisch, N. Quednau et al., "A novel porcine in vitro model of the blood-cerebrospinal fluid barrier with strong barrier function," PLoS ONE, vol. 7, no. 6, Article ID e39835, 2012.
96. M. Haselbach, J. Wegener, S. Decker, C. Engelbertz, and H.-J. Galla, "Porcine choroid plexus epithelial cells in culture: regulation of barrier properties and transport processes," Microscopy Research and Technique, vol. 52, no. 1, pp. 137-152, 2001.
97. I. Ishiwata, C. Ishiwata, E. Ishiwata et al., "Establishment and characterization of a human malignant choroids plexus papilloma cell line (HIBCPP)," Human Cell, vol. 18, no. 1, pp. 67-72, 2005.
98. J. Kläs, H. Wolburg, T. Terasaki, G. Fricker, and V. Reichel, "Characterization of immortalized choroid plexus epithelial cell lines for studies of transport processes across the bloodcerebrospinal fluid barrier," Cerebrospinal Fluid Research, vol. 7, article 11, 2010.
99. T. Tenenbaum, U. Steinmann, C. Friedrich, J. Berger, C. Schwerk, and H. Schroten, "Culture models to study leukocyte trafficking across the choroid plexus," Fluids and Barriers of the CNS, vol. 10, no. 1, article 1, 2013.
100. W. W. Suen, N. A. Prow, Y. X. Setoh et al., "End-point disease investigation for virus strains of intermediate virulence as illustrated by flavivirus infections," Journal of General Virology, vol. 97, no. 2, pp. 366-377, 2016.
101. J. Seok, H. S. Warren, A. G. Cuenca et al., "Genomic responses in mouse models poorly mimic human inflammatory diseases," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 9, pp. 3507-3512, 2013.
102. J. B. Graham, S. Thomas, J. Swarts et al., "Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes," MBio, vol. 6, no. 3, pp. e00493-e00415, 2015.
103. S. J. Allen, S. E. Crown, and T.M. Handel, "Chemokine: receptor structure, interactions, and antagonism," Annual Review of Immunology, vol. 25, pp. 787-820, 2007.
104. M. P. Hosking and T. E. Lane, "The role of chemokines during viral infection of the CNS," PLoS Pathogens, vol. 6, no. 7, Article ID e1000937, 2010.
105. A. Zlotnik and O. Yoshie, "Chemokines: a new classification system and their role in immunity," Immunity, vol. 12, no. 2, pp. 121-127, 2000.
106. L. C. Borish and J. W. Steinke, "2. Cytokines and chemokines," Journal of Allergy and Clinical Immunology, vol. 111, no. 2, supplement, pp. S460-S475, 2003.
107. A. Sulik, A. Kroten, M. Wojtkowska, and E. Oldak, "Increased levels of cytokines in cerebrospinal fluid of children with aseptic meningitis caused by mumps virus and echovirus 30," Scandinavian Journal of Immunology, vol. 79, no. 1, pp. 68-72, 2014.
108. M. S. Bastos, J. G. Coelho-Dos-Reis, D. A. G. Zauli et al., "Divergent cerebrospinal fluid cytokine network induced by non-viral and different viral infections on the central nervous system," BMC Infectious Diseases, vol. 15, no. 1, article 345, 2015.
109. S.-M. Wang, H.-Y. Lei, and C.-C. Liu, "Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis," Clinical and Developmental Immunology, vol. 2012, Article ID 876241, 8 pages, 2012.
110. K. Kothur, L. Wienholt, F. Brilot, and R. C. Dale, "CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review," Cytokine, vol. 77, pp. 227-237, 2016.
111. K. Frei, U. V. Malipiero, T. P. Leist, R. M. Zinkernagel, M. E. Schwab, and A. Fontana, "On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases," European Journal of Immunology, vol. 19, no. 4, pp. 689-694, 1989.
112. T. Kishimoto, "Interleukin-6: From basic science to medicine- 40 Years in immunology," Annual Review of Immunology, vol. 23, pp. 1-21, 2005.
113. D. M. Durrant, B. P. Daniels, and R. S. Klein, "IL-1R1 signaling regulates CXCL12-mediated T cell localization and fate within the central nervous systemduring West Nile Virus encephalitis," The Journal of Immunology, vol. 193, no. 8, pp. 4095-4106, 2014.
114. E. E. McCandless, Q. Wang, B. Mark Woerner, J. M. Harper, and R. S. Klein, "CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis," Journal of Immunology, vol. 177, no. 11, pp. 8053-8064, 2006.
115. S. Osmanov, C. Pattou, N. Walker et al., "Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000," Journal of Acquired Immune Deficiency Syndromes, vol. 29, no. 2, pp. 184-190, 2002.
116. M. Sanmarti, L. Ibanez, S. Huertas et al., "HIV-associated neurocognitive disorders," Journal of Molecular Psychiatry, vol. 2, no. 1, p. 2, 2014.
117. M. Toborek, Y. W. Lee, G. Flora et al., "Mechanisms of the blood-brain barrier disruption in HIV-1 infection," Cellular and Molecular Neurobiology, vol. 25, no. 1, pp. 181-199, 2005.
118. N. Chomont, M. El-Far, P. Ancuta et al., "HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation," Nature Medicine, vol. 15, no. 8, pp. 893-900, 2009.
119. T.-W. Chun, L. Carruth, D. Finzi et al., "Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection," Nature, vol. 387, no. 6629, pp. 183-188, 1997.
120. L. Redel, V. Le Douce, T. Cherrier et al., "HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes," Journal of Leukocyte Biology, vol. 87, no. 4, pp. 575-588, 2010.
121. B. F. Keele, E. E. Giorgi, J. F. Salazar-Gonzalez et al., "Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 21, pp. 7552-7557, 2008.
122. E. A. Eugenin, K. Osiecki, L. Lopez, H. Goldstein, T. M. Calderon, and J.W. Berman, "CCL2/monocyte chemoattractant protein-1mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the bloodbrain barrier: a potentialmechanism of HIV-CNS invasion and Neuro AIDS," The Journal of Neuroscience, vol. 26, no. 4, pp. 1098-1106, 2006.
123. C. T. Costiniuk and M.-A. Jenabian, "Cell-to-cell transfer of HIV infection: implications for HIV viral persistence," Journal of General Virology, vol. 95, pp. 2346-2355, 2014.
124. D.W. Williams, T. M. Calderon, L. Lopez et al., "Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+monocytes to CCL2 and key roles of CCR2, JAMA, and ALCAM in diapedesis," PLoS ONE, vol. 8, no. 7, Article ID e69270, 2013.
125. M. Kaul, G. A. Garden, and S. A. Lipton, "Pathways to neuronal injury and apoptosis in HIV-associated dementia," Nature, vol. 410, no. 6831, pp. 988-994, 2001.
126. D. W. Williams, E. A. Eugenin, T. M. Calderon, and J. W. Berman, "Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis," Journal of Leukocyte Biology, vol. 91, no. 3, pp. 401-415, 2012.
127. K. E. Peterson, S. J. Robertson, J. L. Portis, and B. Chesebro, "Differences in cytokine and chemokine responses during neurological disease induced by polytropicmurine retroviruses map to separate regions of the viral envelope gene," Journal of Virology, vol. 75, no. 6, pp. 2848-2856, 2001.
128. L. Yuan, L. Qiao, F. Wei et al., "Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China," Journal of Neuro Virology, vol. 19, no. 2, pp. 144-149, 2013.
129. R. J. Whitley and B. Roizman, "Herpes simplex virus infections," The Lancet, vol. 357, no. 9267, pp. 1513-1518, 2001.
130. M. F. Kramer, W. J. Cook, F. P. Roth et al., "Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression," Journal of Virology, vol. 77, no. 17, pp. 9533-9541, 2003.
131. J. Piret and G. Boivin, "Innate immune response during herpes simplex virus encephalitis and development of immunomodulatory strategies," Reviews in Medical Virology, vol. 25, no. 5, pp. 300-319, 2015.
132. S. F. Mekan, M. Wasay, B. Khelaeni, Z. Saeed, A. Hassan, and M. Sheerani, "Herpes simplex encephalitis: analysis of 68 cases from a tertiary care hospital in Karachi, Pakistan," Journal of the Pakistan Medical Association, vol. 55, no. 4, pp. 146-148, 2005.
133. T. R. Wuest and D. J. J. Carr, "Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection," The Journal of Immunology, vol. 181, no. 11, pp. 7985-7993, 2008.
134. M. Baggiolini, "Chemokines and leukocyte traffic," Nature, vol. 392, no. 6676, pp. 565-568, 1998.
135. M. M. Teixeira, M. C. Vilela, F. M. Soriani, D. H. Rodrigues, and A. L. Teixeira, "Using intravital microscopy to study the role of chemokines during infection and inflammation in the central nervous system," Journal of Neuroimmunology, vol. 224, no. 1-2, pp. 62-65, 2010.
136. D. J. J. Carr, J. Ash, T. E. Lane, and W. A. Kuziel, "Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1," Journal of General Virology, vol. 87, part 3, pp. 489-499, 2006.
137. S. S. Ousman and P. Kubes, "Immune surveillance in the central nervous system," Nature Neuroscience, vol. 15, no. 8, pp. 1096-1101, 2012.
138. C. D. Conrady, M. Thapa, T. Wuest, and D. J. J. Carr, "Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice," The Journal of Immunology, vol. 182, no. 6, pp. 3678-3687, 2009.
139. N. Boivin, R. Menasria, D. Gosselin, S. Rivest, and G. Boivin, "Impact of deficiency in CCR2 and CX3CR1 receptors on monocytes trafficking in herpes simplex virus encephalitis," Journal of General Virology, vol. 93, part 6, pp. 1294-1304, 2012.
140. S. Wickham, B. Lu, J. Ash, and D. J. J. Carr, "Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis," Journal of Neuroimmunology, vol. 162, no. 1-2, pp. 51-59, 2005.
141. A. Rösler, M. Pohl, H.-J. Braune, W. H. Oertel, D. Gemsa, and H. Sprenger, "Timecourse of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis," Journal of the Neurological Sciences, vol. 157, no. 1, pp. 82-89, 1998.
142. C. M. Dorobantu, L. Albulescu, C. Harak et al., "Modulation of the host lipid landscape to promote RNA virus replication: the picornavirus encephalomyocarditis virus converges on the pathway used by hepatitis C virus," PLoS Pathogens, vol. 11, no. 9, Article ID e1005185, 2015.
143. R. T. Johnson, E. L. Buescher, N.G. Rogers, M. J. Funkenbusch, and W. E. Oliu, "Epidemic central nervous system disease of mixed enterovirus etiology: analysis of laboratory investigations," American Journal of Epidemiology, vol. 71, no. 3, pp. 331-341, 1960.
144. H. Rudolph, H. Schroten, and T. Tenenbaum, "Enterovirus infections of the central nervous system in children-an update," The Pediatric Infectious Disease Journal, vol. 35, no. 5, pp. 567-569, 2016.
145. R. Feuer, C. M. Ruller, N. An et al., "Viral persistence and chronic immunopathology in the adult central nervous system following coxsackievirus infection during the neonatal period," Journal of Virology, vol. 83, no. 18, pp. 9356-9369, 2009.
146. M. Sato, M. Hosoya, K. Honzumi et al., "Cytokine and cellular inflammatory sequence in enteroviral meningitis," Pediatrics, vol. 112, no. 5, pp. 1103-1107, 2003.
147. S.-M. Wang, H.-Y. Lei, C.-K. Yu, J.-R. Wang, I.-J. Su, and C.-C. Liu, "Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis," Journal of Infectious Diseases, vol. 198, no. 7, pp. 1002-1006, 2008.
148. L. M. Huffman, B. T. Fife, W. S. Begolka, S. D. Miller, and W. J. Karpus, "Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease," Journal of Neuro Virology, vol. 5, no. 6, pp. 635-642, 1999.
149. J. S. Mackenzie, D. J. Gubler, and L. R. Petersen, "Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses," Nature Medicine, vol. 10, supplement 12, pp. S98-S109, 2004.
150. M. K. Goverdhan, A. B. Kulkarni, A. K. Gupta, C. D. Tupe, and J. J. Rodrigues, "Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques," Acta Virologica, vol. 36, no. 3, pp. 277-283, 1992.
151. A. H. Eldadah and N. Nathanso, "Pathogenesis ofwest nile virus encephalitis in mice and rats. 2. Virus multiplication evolution of immunofluorescence and development of histological lesions in brain," American Journal of Epidemiology, vol. 86, no. 3, p. 776, 1967.
152. R. B. Tesh, M. Siirin, H. Guzman et al., "Persistent West Nile Virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections," Journal of Infectious Diseases, vol. 192, no. 2, pp. 287-295, 2005.
153. M. L. Bunning, R. A. Bowen, C. B. Cropp et al., "Experimental infection of horses with West Nile virus," Emerging Infectious Diseases, vol. 8, no. 4, pp. 380-386, 2002.
154. N. Charlier, P. Leyssen, E. D. Clercq, and J. Neyts, "Rodent models for the study of therapy against flavivirus infections," Antiviral Research, vol. 63, no. 2, pp. 67-77, 2004.
155. R. S. Klein, E. Lin, B. Zhang et al., "Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis," Journal of Virology, vol. 79, no. 17, pp. 11457-11466, 2005.
156. W. G. Glass, J. K. Lim, R. Cholera, A. G. Pletnev, J.-L. Gao, and P. M. Murphy, "Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection," Journal of Experimental Medicine, vol. 202, no. 8, pp. 1087-1098, 2005.
157. B. Zhang, K. C. Ying, B. Lu, M. S. Diamond, and R. S. Klein, "CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during west nile virus encephalitis," The Journal of Immunology, vol. 180, no. 4, pp. 2641-2649, 2008.
158. B. Shrestha and M. S. Diamond, "Role of CD8+ T cells incontrol of West Nile virus infection," Journal of Virology, vol. 78, no. 15, pp. 8312-8321, 2004.
159. K. Shirato, T. Kimura, T. Mizutani, H. Kariwa, and I. Takashima, "Different chemokine expression in lethal and non-lethal murine West Nile virus infection," Journal of Medical Virology, vol. 74, no. 3, pp. 507-513, 2004.
160. E. E. McCandless, B. Zhang, M. S. Diamond, and R. S. Klein, "CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 32, pp. 11270-11275, 2008.
161. N. A. Prow and D. N. Irani, "The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis," Journal of Neurochemistry, vol. 105, no. 4, pp. 1276-1286, 2008.
162. D. M. Durrant, M. L. Robinette, and R. S. Klein, "IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during west Nile virus encephalitis," The Journal of Experimental Medicine, vol. 210, no. 3, pp. 503-516, 2013.
163. B. S. Kim, Y.-H. Jin, L. Meng et al., "IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease," Journal of Neuroinflammation, vol. 9, article 217, 2012.
164. H. J. Ramos, M. C. Lanteri, G. Blahnik et al., "IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection," PLoS Pathogens, vol. 8, no. 11, Article ID e1003039, 2012.
165. S. V. Bardina, D. Michlmayr, K.W. Hoffman et al., "Differential roles of chemokines CCL2 and CCL7 in monocytosis and leukocyte migration during West Nile virus infection," Journal of Immunology, vol. 195, no. 9, pp. 4306-4318, 2015.
166. R. L. Terry, D. R. Getts, C. Deffrasnes, C. van Vreden, I. L. Campbell, and N. J. C. King, "Inflammatory monocytes and the pathogenesis of viral encephalitis," Journal of Neuroinflammation, vol. 9, article 270, 2012.
167. C.-L. Tsou, W. Peters, Y. Si et al., "Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites," The Journal of Clinical Investigation, vol. 117, no. 4, pp. 902-909, 2007.
168. D. Trobaugh and S. Green, "Of mice and men: protective and pathogenic immune responses to west Nile virus infection," Current Tropical Medicine Reports, vol. 2, no. 1, pp. 41-48, 2015.
169. C. E. Patterson, J. K. Daley, L. A. Echols, T. E. Lane, and G. F. Rall, "Measles virus infection induces chemokine synthesis by neurons," Journal of Immunology, vol. 171, no. 6, pp. 3102-3109, 2003.
170. T. Asano, K. Ichiki, S. Koizumi et al., "Enhanced expression of cytokines/chemokines in cerebrospinal fluids in mumps meningitis in children," Pediatrics International, vol. 53, no. 2, pp. 143-146, 2011.
171. A. Lo Presti, A. Lai, E. Cella, G. Zehender, and M. Ciccozzi, "Chikungunya virus, epidemiology, clinics and phylogenesis: a review," Asian Pacific Journal of Tropical Medicine, vol. 7, no. 12, pp. 925-932, 2014.
172. S. M. Volk, R. Chen, K. A. Tsetsarkin et al., "Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates," Journal of Virology, vol. 84, no. 13, pp. 6497-6504, 2010.
173. R. S. Nasci, "Movement of chikungunya virus into the Western hemisphere," Emerging Infectious Diseases, vol. 20, no. 8, pp. 1394-1395, 2014.
174. I. Schuffenecker, I. Iteman, A. Michault et al., "Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak," PLoS Medicine, vol. 3, no. 7, article e263, 2006.
175. N. H. Chandak, R. S. Kashyap, D. Kabra et al., "Neurological complications of Chikungunya virus infection," Neurology India, vol. 57, no. 2, pp. 177-180, 2009.
176. A.M. Powers and C. H. Logue, "Changing patterns of chikunya virus: re-emergence of a zoonotic arbovirus," Journal of General Virology, vol. 88, no. 9, pp. 2363-2377, 2007.
177. M. Sourisseau, C. Schilte, N. Casartelli et al., "Characterization of reemerging chikungunya virus," PLoS Pathogens, vol. 3, no. 6, article e89, 2007.
178. R. Priya, I. K. Patro, and M. M. Parida, "TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus," Virus Research, vol. 189, pp. 194-205, 2014.
179. R. Priya, R. Dhanwani, I.K. Patro, P.V.L. Rao, and M.M. Parida, "Differential regulation of TLR mediated innate immune response ofmouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1: A226V mutation," Infection, Genetics and Evolution, vol. 20, pp. 396-406, 2013.